Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 22(3): 703-12, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17928358

ABSTRACT

Methylene blue (MB) has been used clinically for about a century to treat numerous ailments. We show that MB and other diaminophenothiazines extend the life span of human IMR90 fibroblasts in tissue culture by >20 population doubling (PDLs). MB delays senescence at nM levels in IMR90 by enhancing mitochondrial function. MB increases mitochondrial complex IV by 30%, enhances cellular oxygen consumption by 37-70%, increases heme synthesis, and reverses premature senescence caused by H2O2 or cadmium. MB also induces phase-2 antioxidant enzymes in hepG2 cells. Flavin-dependent enzymes are known to use NAD(P)H to reduce MB to leucomethylene blue (MBH2), whereas cytochrome c reoxidizes MBH2 to MB. Experiments on lysates from rat liver mitochondria suggest the ratio MB/cytochrome c is important for the protective actions of MB. We propose that the cellular senescence delay caused by MB is due to cycling between MB and MBH2 in mitochondria, which may partly explain the increase in specific mitochondrial activities. Cycling of MB between oxidized and reduced forms may block oxidant production by mitochondria. Mitochondrial dysfunction and oxidative stress are thought to be key aberrations that lead to cellular senescence and aging. MB may be useful to delay mitochondrial dysfunction with aging and the decrease in complex IV in Alzheimer disease.


Subject(s)
Cellular Senescence/drug effects , Methylene Blue/pharmacology , Mitochondria, Liver/metabolism , Oxygen/metabolism , Signal Transduction/drug effects , Animals , Cadmium/antagonists & inhibitors , Cadmium/toxicity , Cells, Cultured , Cytochromes c/metabolism , Enzyme Induction/drug effects , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Hydrogen Peroxide/antagonists & inhibitors , Hydrogen Peroxide/toxicity , Male , Methylene Blue/chemistry , Mitochondria, Liver/drug effects , Oxidants/antagonists & inhibitors , Oxidants/toxicity , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Oxygen Consumption/drug effects , Quinone Reductases/metabolism , Rats , Rats, Inbred F344 , Thioredoxin Reductase 1/metabolism , Time Factors
2.
J Ethnopharmacol ; 111(1): 1-7, 2007 Apr 20.
Article in English | MEDLINE | ID: mdl-17166678

ABSTRACT

This work assessed the mechanism underlying the antisecretory gastric acid effect of Plectranthus barbatus Andrews (Lamiaceae) and active constituents. Popularly known as "false-boldo", this plant is used in Brazilian folk medicine to treat gastrointestinal and hepatic ailments. The plant aqueous extract (AE) and isolated compounds were assayed in vivo in pylorus-ligated mice, and in vitro on acid secretion measured as [(14)C]-aminopyrine ([(14)C]-AP) accumulation in rabbit gastric glands and gastric H(+),K(+)-ATPase preparations. Injected into the duodenal lumen, the AE of the plant leaves (0.5 and 1.0 g/kg) decreased the volume (62 and 76%) and total acidity (23 and 50%) of gastric acid secretion in pylorus-ligated mice. Bioguided purification of the AE yielded an active fraction (IC(50)=24 microg/ml) that inhibited acid secretion in rabbit gastric glands with a potency 10 to 18 times greater than that of the originating extract, on both the basal and stimulated acid secretion by histamine (His) (1 microM) or bethanechol (100 microM). At the same concentrations the gastric H(+),K(+)-ATPase activity was also inhibited. The active constituent was chemically identified as the abietanoid dienedione plectrinone A which reduced the H(+),K(+)-ATPase activity with IC(50)=171 microM. The results indicate that inhibition of the gastric proton pump by this diterpenoid may account for the antisecretory acid effect and reputed anti ulcer activity of Plectranthus barbatus.


Subject(s)
Abietanes/pharmacology , Anti-Ulcer Agents/pharmacology , Enzyme Inhibitors/pharmacology , Gastric Acid/metabolism , Lamiaceae , Proton Pump Inhibitors , Stomach/drug effects , Abietanes/isolation & purification , Aminopyrine/metabolism , Animals , Anti-Ulcer Agents/isolation & purification , Bethanechol/pharmacology , Brazil , Chemical Fractionation/methods , Dose-Response Relationship, Drug , Enzyme Inhibitors/isolation & purification , Gastric Acidity Determination , Gastric Mucosa/drug effects , Gastric Mucosa/enzymology , H(+)-K(+)-Exchanging ATPase/metabolism , Histamine/pharmacology , In Vitro Techniques , Male , Mice , Muscarinic Agonists/pharmacology , Plant Leaves , Rabbits , Stomach/enzymology
3.
J Nutr ; 137(1): 25-30, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17182796

ABSTRACT

Four of the 5 biotin-dependent carboxylases (BDC) are in the mitochondria. BDC replace intermediates in the Krebs [tricarboxylic acid (TCA)] cycle that are regularly removed for the synthesis of key metabolites such as heme or amino acids. Heme, unlike amino acids, is not recycled to regenerate these intermediates, is not utilized from the diet, and must be synthesized in situ. We studied whether biotin deficiency (BD) lowers heme synthesis and whether mitochondria would be disrupted. Biotin-deficient medium was prepared by using bovine serum stripped of biotin with charcoal/dextran or avidin. Biotin-deficient primary human lung fibroblasts (IMR90) lost their BDC and senesced before biotin-sufficient cells. BD caused heme deficiency; there was a decrease in heme content and heme synthesis, and biotin-deficient cells selectively lost mitochondrial complex IV, which contains heme-a. Loss of complex IV, which is part of the electron transport chain, triggered oxidant release and oxidative damage, hallmarks of heme deficiency. Restoring biotin to the biotin-deficient medium prevented the above changes. Old cells were more susceptible to biotin shortage than young cells. These findings highlight the biochemical connection among biotin, heme, and iron metabolism, and the mitochondria, due to the role of biotin in maintaining the biochemical integrity of the TCA cycle. The findings are discussed in relation to aging and birth defects in humans.


Subject(s)
Biotin/deficiency , Fibroblasts/metabolism , Heme/antagonists & inhibitors , Heme/biosynthesis , Lung/cytology , Mitochondria/metabolism , Chromatography, High Pressure Liquid , Fibroblasts/drug effects , Humans , Kinetics , Lung/drug effects , Lung/metabolism , Mitochondria/drug effects , Models, Biological , Oxidants/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...